DOES IMMUNOSUPPRESSIVE TREATMENT AMELIORATE MORPHOLOGY CHANGES IN ENCAPSULATING PERITONEAL SCLEROSIS?
Articles > Article · 2009
Authors: Devrim BOZKURT, Savas SIPAHI, Pinar CETIN, Ender HUR, Ozden OZDEMIR, Muhittin ERTILAV, Sait ŞEN, Soner DUMAN
PERITONEAL DIALYSIS INTERNATIONAL, Journal Indexed in SCI Expanded, International, 2009, vol 29
Summary
Encapsulating peritoneal sclerosis (EPS) is a clinical syndrome associated with ileus symptoms and irreversible sclerosis of the peritoneal membrane. Inflammation, fibrosis, and neoangiogenesis are the main features of the pathophysiology. No evidence-based therapy is currently available for EPS. In recent years, anti-inflammatory and immunosuppressive (IS) treatment modalities have become more popular.